A two model receptor system of the alpha1D adrenergic receptor to describe interactions with epinephrine and BMY7378

Journal of Chemical Information and Modeling

Volumn 46, Issue 1, 2006, Pages 334-344

  Bautista, Debra L ^a,b   Morris, Deanna H ^a   Stein, Lauren ^a   Asher, Wesley ^a   Hammitt, Timothy ^a  

^a EASTERN KENTUCKY UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; HYDROGEN BONDS; MATHEMATICAL MODELS;

EPINEPHRINE; LIGANDS; PROTONATION; RECEPTORS;

PROTEINS;

8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; LIGAND; PIPERAZINE DERIVATIVE;

ARTICLE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; METABOLISM; PROTEIN CONFORMATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; COMPUTER SIMULATION; EPINEPHRINE; LIGANDS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PIPERAZINES; PROTEIN CONFORMATION; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 33244482256     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci050116k     Document Type: Conference Paper

References (34)

1. Palczewski, K.; Kumasaka, T.; Horf, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Trong, I. L.; Teller, D. C.; Okada, T.; Stemkamp, R. E.; Yamamoto, M.; Muyano, M. Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor. Science 2000, 289, 739-745.
2. Klabunde, T.; Hessler, G. Drug design strategies for targeting G-protein-coupled receptors. Chembiochem 2002, 3 (10), 928-44.
3. Tranquilli, W. J.; Thurmon, J. C.; Benson, G. J. Alterations in the arrhythmogenic dose of epinephrine after adrenergic receptor blockade with prazosin, metoprolol, or yohimbine in halothane-xylazine-anesthetized dogs. Am. J. Vet. Res. 1986, 47 (1), 114-8.
4. Todd, E. P.; Vick, R. L. Kalemotropic effect of epinephrine: analysis with adrenergic agonists and antagonists. Am. J. Physiol. 1971, 220 (6), 1964-9.
5. Hancock, A. A.; Kyncl, J. J.; Martin, Y. C.; DeBernardis, J. F. Differentiation of alpha-adrenergic receptors using pharmacological evaluation and molecular modeling of selective adrenergic agents. J. Recept. Res. 1988, 8 (1-4), 23-46.
6. Chen, S.; Lin, F.; Xu, M.; Riek, R. P.; Novotny, J.; Graham, R. M. Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations. Biochemistry 2002, 41 (19), 6045-53.
7. Fanelli, F.; Menziani, C.; Scheer, A.; Cotecchia, S.: De Benedetti, P. G. Ab initio modeling and molecular dynamics simulation of the alpha 1b-adrenergic receptor activation. Methods 1998, 14 (3), 302-17.
8. Mialet-Perez, J.; Green, S. A.; Miller, W. E.; Liggett, S. B. A primate-dominant third glycosylation site of the beta2-adrenergic receptor routes receptors to degradation during agonist regulation. J. Biol. Chem. 2004, 279 (37), 38603-7.
9. Wilcox, R. E.; Tseng, T.; Brusniak, M. Y.; Ginsburg, B.; Pearlman, R. S.; Teeter, M.; DuRand, C.; Starr, S.; Neve, K. A. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. J. Med. Chem. 1998, 41 (22), 4385-99.
10. Zuscik, M. J.; Porter, J. E.; Gaivin, R.; Perez, D. M. Identification of a conserved switch residue responsible for selective constitutive activation of the beta2-adrenergic receptor. J. Biol. Chem. 1998, 273 (6), 3401-7.
11. Parrill, A. L.; Wang, D.; Bautista, D. L.; Van Brocklyn, J. R.; Lorincz, Z.; Fischer, D. J.; Baker, D. L.; Liliom, K.; Spiegel, S.; Tigyi, G. Identification of Edgl receptor residues that recognize sphingosine 1-phosphate. J. Biol. Chem. 2000, 275 (50), 39379-84.
12. Hoflack, J.; Trump-Kallmeyer, S.; Hibert, M. Re-evaluation of bacteriorhodopsin as a model of G protein-coupled receptors. TiPS 1994, 15, 7-9.
13. Bissantz, C.; Bernard, P.; Hibert, M.; Rognan, D. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? Proteins 2003, 50 (1), 5-25.
14. Sardar, V. M.; Bautista, D. L.; Fischer, D. J.; Yokoyama, K.; Nusser, N.; Virag, T.; Wang, D. A.; Baker, D. L.; Tigyi, G.; Parrill, A. L. Molecular basis for lysophosphatidic acid receptor antagonist selectivity. Biochim. Biophys. Acta 2002, 7582 (1-3), 309-17.
15. Bautista, D. L.; Baker, D. L.; Wang, D.; Fischer, D. J.; Van Brocklyn, J.; Spiegel, S.; Tigyi, G.; Parrill, A. L. Dynamic Modeling of EDG1 Receptor Structural Changes Induced by Site-Directed Mutations. THEOCHEM 2000, 529, 219-224.
16. Parrill, A. L.; Baker, D. L.; Wang, D.; Fischer, D. J.; van Brocklyn, J.; Spiegel, S.; Tigyi, G.; Bautista, D. L. Structural Features of EDG1 Receptor-Ligand Complexes Revealed by Computational Modeling and Mutagenesis. In Lysophospholipids and Eicosanoids in Biology and Pathophysiology; Goetzl, E. J., Lynch, K. R., Eds.; New York Academy of Sciences: New York, 2000; Vol. 905, pp 330-339.
17. Fischer, D. J.; Nusser, N.; Virag, T.; Yokoyama, K.; Wang, D.; Baker, D. L.; Bautista, D.; Parrill, A. L.; Tigyi, G. Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors. Mol. Pharmacol. 2001, 60 (4), 776-84.
18. Wang, D. A.; Lorincz, Z.; Bautista, D. L.; Liliom, K.; Tigyi, G.; Parrill, A. L. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors. J. Biol. Chem. 2001, 276 (52), 49213-20.
19. Goetz, A. S.; King, H. K.; Ward, S. D.; True, T. A.; Rimele, T. J.; Saussy, D. L., Jr. BMY 7378 is a selective antagonist of the D subtype of alpha 1 -adrenoceptors. Eur. J. Pharmacol. 1995, 272 (2-3), R5-6.
20. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235-242.
21. MOE, 1998.10; Chemical Computing Group: Montreal, 1998.
22. van Rhee, A. M.; Jacobson, K. A. Molecular Architecture of G Protein-Coupled Receptors. Drug Dev. Res. 1996, 37, 1-38.
23. Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M. J.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.: Kollman, P. A. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules. J. Am. Chem. Soc. 1995, 117 (19), 5179-5197.
24. Halgren, T. A. Merck Molecular Force Field. I. Basis Form, Scope Parameterization, and Preformance of MMFF94*. J. Comput. Chem. 1996. 17 (5&6), 490-519.
25. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19 (14), 1639-1662.
26. Konvicka, K.; Ballesteros, J. A.; Weinstein, H. A Proposed Structure for Transmembrane Segment 7 of G Protein-Coupled Receptors Incorporating an Asn-Pro/Asp-Pro Motif. Biophys. J. 1998, 75, 601-611.
27. Strader, C. D.; Sigal, I. S.; Register, R. B.; Candelore, M. R.; Rands, E.; Dixon, R. A. Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 1987, 84 (13), 4384-8.
28. Waugh, D. J.; Gaivin, R. J.; Zuscik, M. J.; Gonzalez-Cabrera, P.; Ross, S. A.; Yun, J.; Perez, D. M. Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists. J. Biol. Chem. 2001, 276 (27), 25366-71.
29. Greasley, P. J.; Fanelli, F.; Rossier, O.; Abuin, L.; Cotecchia, S. Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol. Phamacol. 2002, 61 (5), 1025-32.
30. Hwa, J.; Perez, D. M. The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation. J. Biol. Chem. 1996, 277 (11), 6322-7.
31. Hwa, J.; Graham, R. M.; Perez, D. M. Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding. J. Biol. Chem. 1995, 270 (39), 23189-95.
32. Hamaguchi, N.; True, T. A.; Goetz, A. S.; Stouffer, M. J.; Lybrand, T. P.; Jeffs, P. W. Alpha 1-adrenergic receptor subtype determinants for 4-piperidyl oxazole antagonists. Biochemistry 1998, 37 (16), 5730-7.
33. Hamaguchi, N.; True, T. A.; Saussy, D. L., Jr.; Jeffs, P. W. Phenylalanine in the second membrane-spanning domain of alpha 1A-adrenergic receptor determines subtype selectivity of dihydropyridine antagonists. Biochemistry 1996, 35 (45), 14312-7.
34. Bautista, D. L.; Penn, W.; Simonetti, K. Computational Investigations of the Octameric Enolase Enzyme. J. Ky. Acad. Sci. 2005, 66 (1).